These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21503945)

  • 1. Profound differences of microRNA expression patterns in hepatocytes and hepatoma cell lines commonly used in hepatitis C virus studies.
    Ehrhardt M; Leidinger P; Keller A; Baumert T; Díez J; Meese E; Meyerhans A
    Hepatology; 2011 Sep; 54(3):1112-3. PubMed ID: 21503945
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic background of hepatocyte cell lines: are in vitro hepatitis C virus research data reliable?
    Bensadoun P; Rodriguez C; Soulier A; Higgs M; Chevaliez S; Pawlotsky JM
    Hepatology; 2011 Aug; 54(2):748. PubMed ID: 21384407
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges.
    Jost I; Shalamova LA; Gerresheim GK; Niepmann M; Bindereif A; Rossbach O
    RNA Biol; 2018; 15(8):1032-1039. PubMed ID: 29486652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
    Zhang J; Ishigaki Y; Takegami T
    Mol Med Rep; 2015 Oct; 12(4):5109-15. PubMed ID: 26151503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma.
    Yeo AE; Tanaka Y; Furuta T
    Hepatology; 2003 Jul; 38(1):267-8; author reply 268-9. PubMed ID: 12830011
    [No Abstract]   [Full Text] [Related]  

  • 6. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
    Steuerwald NM; Parsons JC; Bennett K; Bates TC; Bonkovsky HL
    Liver Int; 2010 Nov; 30(10):1490-504. PubMed ID: 20825557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines.
    Xiao CW; Xue XB; Zhang H; Gao W; Yu Y; Chen K; Zheng JW; Wang CJ
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):615-21. PubMed ID: 21134831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
    Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
    Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
    Dou J; Liu P; Wang J; Zhang X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
    Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
    World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma].
    Aihara T; Miyoshi Y; Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1747-53. PubMed ID: 9279108
    [No Abstract]   [Full Text] [Related]  

  • 15. [HCV-related hepatocellular carcinoma].
    Otsuka M; Kato N; Yoshida H; Yoshida H; Shiratori Y; Omata M
    Uirusu; 2002 Dec; 52(2):295-300. PubMed ID: 12685322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of hepatocellular carcinoma type C and B by quantitation of serum HCV-RNA and HBV-DNA using branched DNA probe assay].
    Teramoto T; Iwabuchi S; Takatori M; Iino S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):787-95. PubMed ID: 7563876
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
    Tiwari I; Yoon MH; Park BJ; Jang KL
    Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncogenes and suppressor oncogenes in C-type hepatocellular carcinoma].
    Tsukiyama-Kohara K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):619-23. PubMed ID: 15359872
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions.
    Abe K; Edamoto Y; Park YN; Nomura AM; Taltavull TC; Tani M; Thung SN
    Hepatology; 1998 Aug; 28(2):568-72. PubMed ID: 9696026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression in hepatitis C virus-related malignancies: A brief review.
    Gragnani L; Piluso A; Fognani E; Zignego AL
    World J Gastroenterol; 2015 Jul; 21(28):8562-8. PubMed ID: 26229398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.